Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
KRMD
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Reasons to Retain Doximity Stock in Your Portfolio for Now
Doximity DOCS is entering a pivotal phase as it accelerates investments in artificial intelligence (AI) to expand beyond its core physician engagement platform. While robust physician adoption, growing enterprise AI deployments and excepti…
Key Points Interested in KORU Medical Systems, Inc.? Here are five stocks we like better. Second-quarter revenue rose 18% to $12 million, driven by domestic patient starts, market-share gains and strong international core revenue growth. K…
KORU Medical Systems, Inc. Q2 2026 Earnings Call Summary
KORU Medical Systems, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Performance Attribution Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it…
Image source: The Motley Fool. DATE Wednesday, May 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Linda TharbyPresident and Chief Commercial Officer — Adam KalbermattenChief Financial Officer — Tom AdamsInvestor Relati…
KORU Medical Systems logo Key Points Q1 revenue was $11.8 million, up 22% YoY, driven by domestic SCIg share gains and 35% international core growth; adjusted EBITDA was essentially break-even and net loss narrowed to $800,000 while cash u…
KORU Medical Systems, Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
KORU Medical Systems, Inc. (KRMD) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items. This…
Inspire Medical Systems (INSP) Q1 Earnings and Revenues Top Estimates
Inspire Medical Systems (INSP) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of a loss of $0.36 per share. This compares to earnings of $0.1 per share a year ago. These figures are adjusted for no…
Phreesia (PHR) Stock Jumps 5.1%: Will It Continue to Soar?
Phreesia PHR shares soared 5.1% in the last trading session to close at $11.77. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 7.4% loss over the past four wee…
KORU Medical Secures EU MDR Certification for Freedom60 Infusion Pump
KORU Medical Systems, Inc. KRMD recently announced that its Freedom60 Infusion Pump — along with an adapter designed for 50 mL prefilled syringes — has secured certification under the European Union Medical Devices Regulation. This approva…
Inspire Medical Systems (INSP) Beats Q4 Earnings and Revenue Estimates
Inspire Medical Systems (INSP) came out with quarterly earnings of $1.65 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $1.15 per share a year ago. These figures are adjusted for non-recurr…
February 2026's Noteworthy Stocks Estimated Below Intrinsic Value
As February 2026 begins, U.S. stock markets have shown a strong start with major indices like the Dow Jones and S&P 500 ending sharply higher, reflecting investor optimism despite ongoing geopolitical and economic uncertainties. In this en…
3 Stocks Estimated To Be Up To 49.8% Below Intrinsic Value
As the United States stock market begins February on a high note with major indexes like the Dow Jones and S&P 500 showing significant gains, investors are keenly observing opportunities amidst fluctuating economic indicators and geopoliti…
BillionToOne Leads 3 Value Stock Picks That May Offer Investment Opportunities
As major stock indexes in the United States have recently experienced significant gains, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing record highs, investors are keenly observing opportunities for value i…
3 Stocks That May Be Undervalued By Market Estimates In February 2026
As February 2026 begins, U.S. stock markets have shown a strong start with major indices like the Dow Jones and S&P 500 ending sharply higher, reflecting investor optimism despite recent economic uncertainties such as delayed jobs data and…
3 MedTech Stocks That Crushed the S&P 500 Over the Past Year
Beating the S&P 500 over a sustained period requires more than headline-driven rallies or short-term multiple expansion. In MedTech, durable outperformance is typically underpinned by structural demand drivers, improving execution and clea…
KRMD Submits 510(k) to Use FreedomEDGE System With Oncology Biologic
KORU Medical Systems, Inc.KRMD recently announced that it has submitted a 510(k) premarket notification for FDA clearance to use its FreedomEDGE infusion system to deliver PHESGO, a breast cancer treatment, under the skin instead of throug…
Here's Why You Should Retain INSP Stock in Your Portfolio Now
Inspire Medical Systems INSP is well poised for growth in the coming quarters amid a major product transition. Management emphasized clinical momentum behind Inspire V, improving reimbursement visibility, and disciplined cost control, whil…
Revvity Advances AI-Driven Scientific Discovery With Signals Xynthetica
Revvity, Inc. RVTY recently introduced Signals Xynthetica, a next-generation AI-augmented design platform aimed at transforming molecular and materials discovery across scientific industries. Positioned within the existing Revvity Signals…
Here's Why You Should Retain CLOV Stock in Your Portfolio Now
Clover Health Investments CLOV is well poised for growth in the coming quarters, courtesy of its broad product spectrum. This optimism is primarily driven by its technology-first care model, as evident from solid membership growth, rising…
KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer
MAHWAH, N.J., December 16, 2025--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on developing, manufacturing, and commercialization of innovative a…
KORU Medical To Seek FDA Clearance For FreedomEDGE Infusion System In Q4 2025/Q1 2026
(RTTNews) - KORU Medical Systems, Inc. (KRMD) is planning to submit a 510(k) application to the FDA for its FreedomEDGE Syringe Infusion System in the fourth quarter of 2025 or in the first quarter of 2026. The submission will seek clearan…
3 Stocks Estimated To Be Trading Below Their Intrinsic Value In November 2025
In the current climate of mixed market performance, with the Dow Jones Industrial Average experiencing fluctuations and tech stocks facing valuation concerns, investors are keenly observing opportunities for potential undervalued assets. A…
Alto Ingredients And 2 Other Penny Stocks To Watch Closely
As the U.S. stock market experiences a sharp downturn, with major indices like the Dow Jones and Nasdaq seeing significant losses, investors are evaluating their portfolios in search of resilient opportunities. Amidst this volatility, penn…
KRMD Shares Rise After Strong Q3 Revenue Growth And Raised 2025 Guidance
(RTTNews) - Shares of KORU Medical Systems Inc. (KRMD) edged higher in early trading today after the company reported robust third-quarter 2025 results and raised its full-year revenue outlook, driven by strong international demand for its…
After-Hours Gainers: MGNX, SLS, KRMD, HYPR, WVE Post Sharp Moves Following Q3 Updates
(RTTNews) - Several small-cap healthcare and biotech names posted notable price increases in after-hours trading on Wednesday, following earnings updates or ahead of scheduled financial disclosures. MacroGenics, Inc. (MGNX) rose 10.2% to $…
KORU Medical Systems projects 20%–22% revenue growth for 2025 while advancing oncology and international expansion
Earnings Call Insights: KORU Medical Systems (KRMD) Q3 2025 MANAGEMENT VIEW * Linda Tharby, President and CEO, reported "accelerating revenue growth, outstanding performance in our core immunoglobulin business, new additions to our PST pip…
KORU Medical Systems, Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates
KORU Medical Systems, Inc. (KRMD) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.03 per share a year ago. These figures are adjusted for non-recurring…
Discovering Opportunities: Penny Stocks To Consider In October 2025
As the major U.S. stock indices recently reached new highs, only to retreat slightly, investors are keenly observing market dynamics and seeking opportunities that align with current economic conditions. Among these opportunities are penny…
Cirtec Medical Announces Appointment of New Chief Executive Officer
BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to announce the appointment of…
Cirtec Medical Announces Appointment of New Chief Executive Officer
BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to announce the appointment of…
KORU Medical at Canaccord Genuity: Expanding Horizons in Drug Delivery
On Wednesday, 13 August 2025, KORU Medical Systems (NASDAQ:KRMD) presented at Canaccord Genuity’s 45th Annual Growth Conference, highlighting its strategic focus on innovative portable drug delivery solutions. The company is optimistic abo…
KORU Medical Systems And 2 Other Penny Stocks To Watch For Growth
As the U.S. stock market continues to reach new heights, with major indices like the S&P 500 and Nasdaq Composite hitting all-time highs, investors are increasingly optimistic about future growth prospects. In this context, penny stocks—th…
KORU Medical Systems raises 2025 revenue outlook to $39.5M–$40.5M with accelerating international growth and new drug pipeline milestones
Earnings Call Insights: KORU Medical Systems (KRMD) Q2 2025 MANAGEMENT VIEW * CEO Linda M. Tharby highlighted that "we reached a historic milestone in Q2 with over $10 million in revenue" and emphasized momentum across all three strategic…
KORU Medical Systems, Inc. (KRMD) Reports Break-Even Earnings for Q2
KORU Medical Systems, Inc. (KRMD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.02 per share a year ago. These figures are adjusted for non-recurring…
Omnicell (OMCL) Beats Q2 Earnings and Revenue Estimates
Omnicell (OMCL) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.51 per share a year ago. These figures are adjusted for non-recurring items. This…
KORU Medical appoints Adam Kalbermatten as chief commercial officer
MAHWAH, N.J. - KORU Medical Systems, Inc. (NASDAQ:KRMD), a medical device company with nearly 20% revenue growth over the past year and a market capitalization of $167 million, announced Monday the appointment of Adam Kalbermatten as Chief…